Skip to main content
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. logo

Zhejiang Shouxiangu Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 603896 ISIN · CNE100002XJ4 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,226 across all filing types
Latest filing 2026-05-19 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 603896

About Zhejiang Shouxiangu Pharmaceutical Co., Ltd.

https://en.sxg1909.com/

Zhejiang Shouxiangu Pharmaceutical Co., Ltd. specializes in the research, cultivation, and production of high-value traditional Chinese medicinal herbs and health products. The company focuses on rare species, notably Ganoderma lucidum (Lingzhi) and Dendrobium officinale. It operates an integrated business model encompassing germplasm resource preservation, organic cultivation, and advanced processing technologies. Key products include broken Ganoderma lucidum spore powder and Dendrobium officinale preparations, which are marketed for their immune-boosting and health-preserving properties. The company emphasizes scientific innovation, utilizing proprietary breeding techniques and standardized production processes to ensure product purity and potency. Its operations are characterized by a commitment to organic standards and the modernization of traditional herbal medicine for global health markets.

Recent filings

Filing Released Lang Actions
寿仙谷2025年年度股东会的法律意见书
Regulatory Filings Classification · 78% confidence The document is a legal opinion letter prepared by a law firm on the convening, attendance, procedural compliance, and voting results of the 2025 annual general meeting. It is neither the AGM presentation or materials (AGM-R) nor a standard proxy solicitation statement (PSI). It does not announce a new financial report, nor is it primarily financial in nature. It is a compliance/legal disclosure that does not fit specific categories such as Board/Management changes, Voting Results only, or Legal Proceedings (lawsuits). Therefore, it falls under the fallback category Regulatory Filings (RNS).
2026-05-19 Chinese
寿仙谷2025年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 91% confidence The document is a ‘2025年度股东会决议公告’ detailing the resolutions passed at the annual shareholders’ meeting, including voting results by proposal and shareholder type. This matches the Definition for ‘Declaration of Voting Results & Voting Rights Announcements’ (Code: DVA).
2026-05-19 Chinese
寿仙谷2025年年度股东会会议资料
AGM Information Classification · 98% confidence The document is titled “2025年年度股东会会议资料” and contains the agenda, meeting guidelines, and proposed resolutions for the company’s 2025 Annual General Meeting. It is clearly a set of materials intended for use at an AGM, rather than a standalone report or announcement of results. Therefore, it falls under AGM Information (Code: AGM-R).
2026-05-11 Chinese
寿仙谷关于举办2026年第一次投资者接待日活动的公告
Regulatory Filings Classification · 95% confidence The document is an announcement about the company's upcoming investor reception day event, including details on the schedule, participants, and registration process. It also references the upcoming 2025 Annual General Meeting (AGM) but does not contain any financial data, results, or report content. The document is relatively short (2843 characters) and serves as a notice to investors about the event rather than a report or transcript. Therefore, it is best classified as a Regulatory Filing (RNS) since it is a general regulatory announcement that does not fit into other specific categories.
2026-05-08 Chinese
寿仙谷关于高级管理人员辞职的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of a senior management personnel, specifically the vice general manager of the company. It details the resignation date, reasons, and confirms no impact on company operations. There is no financial data, no mention of financial results, no audit information, no voting results, no legal proceedings, no capital changes, and no report publication. The content clearly fits the category of management changes. Therefore, the document is best classified as Board/Management Information (MANG). The document length is short and focused solely on management change, supporting this classification with high confidence.
2026-05-07 Chinese
寿仙谷董事会对独立董事独立性自查情况的专项报告
Governance Information Classification · 90% confidence The document is a formal board-issued special report evaluating the independence of its independent directors, citing corporate governance regulations (CSRC and SSE rules) and detailing internal governance practices. This aligns with the definition of a Governance Information report, as it focuses on internal rules and board governance. It is not an announcement of another document’s publication, nor does it cover financial results, management changes, or other categories.
2026-04-28 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.